{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:03:24Z","timestamp":1762866204989},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,18]],"date-time":"2013-08-18T00:00:00Z","timestamp":1376784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11936-013-0265-2","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T07:21:25Z","timestamp":1376724085000},"page":"544-555","source":"Crossref","is-referenced-by-count":28,"title":["Carcinoid Valve Disease"],"prefix":"10.1007","volume":"15","author":[{"given":"J. Wells","family":"Askew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,18]]},"reference":[{"key":"265_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","volume":"79","author":"IM Modlin","year":"1997","unstructured":"Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813\u201329.","journal-title":"Cancer"},{"key":"265_CR2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","volume":"87","author":"PA Pellikka","year":"1993","unstructured":"Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188\u201396.","journal-title":"Circulation"},{"key":"265_CR3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","volume":"77","author":"L Lundin","year":"1988","unstructured":"Lundin L, Norheim I, Landelius J, et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation. 1988;77:264\u20139.","journal-title":"Circulation"},{"key":"265_CR4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-8703(97)70053-X","volume":"134","author":"AS Anderson","year":"1997","unstructured":"Anderson AS, Krauss D, Lang R. Cardiovascular complications of malignant carcinoid disease. Am Heart J. 1997;134:693\u2013702.","journal-title":"Am Heart J."},{"key":"265_CR5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","volume":"101","author":"S Bhattacharyya","year":"2008","unstructured":"Bhattacharyya S, Toumpanakis C, Caplin ME, et al. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol. 2008;101:378\u201381.","journal-title":"Am J Cardiol"},{"key":"265_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CRD.0b013e31824c866e","volume":"20","author":"C Palaniswamy","year":"2012","unstructured":"Palaniswamy C, Frishman WH, Aronow WS. Carcinoid heart disease. Cardiol Rev. 2012;20:167\u201376. doi: 10.1097\/CRD.1090b1013e31824c31866e .","journal-title":"Cardiol Rev"},{"key":"265_CR7","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjcard.2004.01.075","volume":"93","author":"N Chaowalit","year":"2004","unstructured":"Chaowalit N, Connolly HM, Schaff HV, et al. Carcinoid heart disease associated with primary ovarian carcinoid tumor. Am J Cardiol. 2004;93:1314\u20135.","journal-title":"Am J Cardiol"},{"key":"265_CR8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/1097-0142(19940401)73:7<1889::AID-CNCR2820730719>3.0.CO;2-3","volume":"73","author":"MA Wilkowske","year":"1994","unstructured":"Wilkowske MA, Hartmann LC, Mullany CJ, et al. Progressive carcinoid heart disease after resection of primary ovarian carcinoid. Cancer. 1994;73:1889\u201391.","journal-title":"Cancer"},{"key":"265_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2006.07.092","volume":"99","author":"AM Bernheim","year":"2007","unstructured":"Bernheim AM, Connolly HM, Pellikka PA. Carcinoid heart disease in patients without hepatic metastases. Am J Cardiol. 2007;99:292\u20134.","journal-title":"Am J Cardiol"},{"key":"265_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0002-9149(97)00340-8","volume":"80","author":"WC Roberts","year":"1997","unstructured":"Roberts WC. A unique heart disease associated with a unique cancer: carcinoid heart disease. Am J Cardiol. 1997;80:251\u20136.","journal-title":"Am J Cardiol"},{"key":"265_CR11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(02)02109-5","volume":"40","author":"UH Pandya","year":"2002","unstructured":"Pandya UH, Pellikka PA, Enriquez-Sarano M, et al. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol. 2002;40:1328\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"265_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0046-8177(76)80054-8","volume":"7","author":"VJ Ferrans","year":"1976","unstructured":"Ferrans VJ, Roberts WC. The carcinoid endocardial plaque: an ultrastructural study. Hum Pathol. 1976;7:387\u2013409.","journal-title":"Hum Pathol"},{"key":"265_CR13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","volume":"49","author":"AM Bernheim","year":"2007","unstructured":"Bernheim AM, Connolly HM, Hobday TJ, et al. Carcinoid heart disease. Prog Cardiovasc Dis. 2007;49:439\u201351.","journal-title":"Prog Cardiovasc Dis"},{"key":"265_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","volume":"77","author":"DV Simula","year":"2002","unstructured":"Simula DV, Edwards WD, Tazelaar HD, et al. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20\u00a0years. Mayo Clinic Proc. 2002;77:139\u201347.","journal-title":"Mayo Clinic Proc."},{"key":"265_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(09)60252-X","volume":"374","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Schapira AH, Mikhailidis DP, et al. Drug-induced fibrotic valvular heart disease. Lancet. 2009;374:577\u201385. Review of potential mechanisms in the development of drug-induced valvular heart disease including interaction of serotonin, serotonin transporter, and 5HT2B receptors. Carcinoid valve disease is believed to be caused by a similar mechanism.","journal-title":"Lancet"},{"key":"265_CR16","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","volume":"102","author":"RB Rothman","year":"2000","unstructured":"Rothman RB, Baumann MH, Savage JE, et al. Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation. 2000;102:2836\u201341.","journal-title":"Circulation"},{"key":"265_CR17","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jtcvs.2009.07.072","volume":"140","author":"B Sareyyupoglu","year":"2010","unstructured":"Sareyyupoglu B, Connolly HM, Schaff HV. Surgical excision of right ventricular carcinoid tumor in a symptomatic patient without carcinoid valve disease. J Thorac Cardiovasc Surg. 2010;140:e23\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"265_CR18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0002-9343(65)90080-X","volume":"39","author":"KL Melmon","year":"1965","unstructured":"Melmon KL, Sjoerdsma A, Mason DT. Distinctive clinical and therapeutic aspects of the syndrome associated with bronchial carcinoid tumors. Am J Med. 1965;39:568\u201381.","journal-title":"Am J Med"},{"key":"265_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ajcn\/42.4.639","volume":"42","author":"JM Feldman","year":"1985","unstructured":"Feldman JM, Lee EM. Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. Am J Clin Nutr. 1985;42:639\u201343.","journal-title":"Am J Clin Nutr"},{"key":"265_CR20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0016-5085(86)90630-X","volume":"91","author":"G Richter","year":"1986","unstructured":"Richter G, Stockmann F, Conlon JM, et al. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology. 1986;91:612\u20138.","journal-title":"Gastroenterology"},{"key":"265_CR21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/00365528809090760","volume":"23","author":"S-M Sj\u00f6blom","year":"1988","unstructured":"Sj\u00f6blom S-M. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scand J Gastroenterol. 1988;23:779\u201387.","journal-title":"Scand J Gastroenterol"},{"key":"265_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00042737-200101000-00010","volume":"13","author":"P Tomassetti","year":"2001","unstructured":"Tomassetti P, Migliori M, Simoni P, et al. Diagnostic value of plasma chromogranin A in neuroendocrine tumours. Eur J Gastroenterol Hepatol. 2001;13:55\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"265_CR23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1245\/s10434-010-1006-3","volume":"17","author":"I Modlin","year":"2010","unstructured":"Modlin I, Gustafsson B, Moss S, et al. Chromogranin A\u2014biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol. 2010;17:2427\u201343.","journal-title":"Ann Surg Oncol"},{"key":"265_CR24","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","volume":"27","author":"CM Korse","year":"2009","unstructured":"Korse CM, Taal BG, de Groot CA, et al. Chromogranin-A and N-Terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. J Clin Oncol. 2009;27:4293\u20139.","journal-title":"J Clin Oncol"},{"key":"265_CR25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0002-9149(89)90150-1","volume":"63","author":"L Lundin","year":"1989","unstructured":"Lundin L, \u00d6berg K, Landelius J, et al. Plasma atrial natriuretic peptide in carcinoid heart disease. Am J Cardiol. 1989;63:969\u201372.","journal-title":"Am J Cardiol"},{"key":"265_CR26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","volume":"102","author":"S Bhattacharyya","year":"2008","unstructured":"Bhattacharyya S, Toumpanakis C, Caplin ME, et al. Usefulness of N-terminal pro\u2013brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease. Am J Cardiol. 2008;102:938\u201342.","journal-title":"Am J Cardiol"},{"key":"265_CR27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","volume":"79","author":"EM Ross","year":"1985","unstructured":"Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985;79:339\u201354.","journal-title":"Am J Med"},{"key":"265_CR28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2011.02.009","volume":"24","author":"KH Haugaa","year":"2011","unstructured":"Haugaa KH, Bergestuen DS, Sahakyan LG, et al. Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease. J Am Soc Echocardiogr. 2011;24:644\u201350.","journal-title":"J Am Soc Echocardiogr"},{"key":"265_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","volume":"3","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya S, Toumpanakis C, Burke M, et al. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging. 2010;3:103\u201311.","journal-title":"Circ Cardiovasc Imaging"},{"key":"265_CR30","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1093\/ejechocard\/jeq099","volume":"12","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya S, Burke M, Caplin ME, et al. Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease. Eur J Echocardiogr. 2011;12:E4.","journal-title":"Eur J Echocardiogr"},{"key":"265_CR31","first-page":"407.e401","volume":"21","author":"KJ Lee","year":"2008","unstructured":"Lee KJ, Connolly HM, Pellikka PA. Carcinoid pulmonary valvulopathy evaluated by real-time 3-dimensional transthoracic echocardiography. J Am Soc Echocardiogr. 2008;21:407.e401\u20132.","journal-title":"J Am Soc Echocardiogr"},{"key":"265_CR32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1540-8175.2012.01781.x","volume":"29","author":"B Dumaswala","year":"2012","unstructured":"Dumaswala B, Bicer EI, Dumaswala K, et al. Live-real time three-dimensional transthoracic echocardiographic assessment of the involvement of cardiac valves and chambers in carcinoid disease. Echocardiography. 2012;29:751\u20136.","journal-title":"Echocardiography."},{"key":"265_CR33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI117090","volume":"93","author":"A Kubota","year":"1994","unstructured":"Kubota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201\u2013995 in treatment of human endocrine tumors. J Clin Invest. 1994;93:1321\u20135.","journal-title":"J Clin Invest"},{"key":"265_CR34","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, M\u00fcller H-H, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group. J Clin Oncol. 2009;27:4656\u201363.","journal-title":"J Clin Oncol"},{"key":"265_CR35","first-page":"833","volume":"26","author":"K \u00d6berg","year":"2012","unstructured":"\u00d6berg K. Biotherapies for GEP-NETs. Best practice & research clinical. Gastroenterology. 2012;26:833\u201341.","journal-title":"Gastroenterology"},{"key":"265_CR36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/02841868709113712","volume":"26","author":"K \u00d6berg","year":"1987","unstructured":"\u00d6berg K, Norheim I, Lundqvist G, et al. Cytotoxic treatment in patients with malignant carcinoid tumors: response to streptozocin\u2014alone or in combination with 5-FU. Acta Oncol. 1987;26:429\u201332.","journal-title":"Acta Oncol"},{"key":"265_CR37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N","volume":"91","author":"SM Ansell","year":"2001","unstructured":"Ansell SM, Pitot HC, Burch PA, et al. A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer. 2001;91:1543\u20138.","journal-title":"Cancer"},{"key":"265_CR38","first-page":"627","volume":"90","author":"U Ritzel","year":"1995","unstructured":"Ritzel U, Leonhardt U, Stockmann F, et al. Treatment of metastasized midgut carcinoids with decarbazine. Am J Gastroenterol. 1995;90:627\u201331.","journal-title":"Am J Gastroenterol"},{"key":"265_CR39","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2009.22.8585","volume":"28","author":"DL Bushnell","year":"2010","unstructured":"Bushnell DL, O'Dorisio TM, O'Dorisio MS, et al. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol. 2010;28:1652\u20139.","journal-title":"J Clin Oncol"},{"key":"265_CR40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2011.03.029","volume":"213","author":"JB Lillegard","year":"2011","unstructured":"Lillegard JB, Fisher JE, McKenzie TJ, et al. Hepatic resection for the carcinoid syndrome in patients with severe carcinoid heart disease: does valve replacement permit safe hepatic resection? J Am Coll Surg. 2011;213:130\u20136.","journal-title":"J Am Coll Surg"},{"key":"265_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0025-6196(11)60834-3","volume":"83","author":"AM Bernheim","year":"2008","unstructured":"Bernheim AM, Connolly HM, Rubin J, et al. Role of hepatic resection for patients with carcinoid heart disease. Mayo Clin Proc. 2008;83:143\u201350.","journal-title":"Mayo Clin Proc"},{"key":"265_CR42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11886-006-0019-9","volume":"8","author":"H Connolly","year":"2006","unstructured":"Connolly H, Pellikka P. Carcinoid heart disease. Curr Cardiol Rep. 2006;8:96\u2013101.","journal-title":"Curr Cardiol Rep."},{"key":"265_CR43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","volume":"25","author":"HM Connolly","year":"1995","unstructured":"Connolly HM, Nishimura RA, Smith HC, et al. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol. 1995;25:410\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"265_CR44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11936-007-0043-0","volume":"9","author":"A Bernheim","year":"2007","unstructured":"Bernheim A, Connolly H, Pellikka P. Carcinoid heart disease. Curr Treat Options Cardio Med. 2007;9:482\u20139.","journal-title":"Curr Treat Options Cardio Med."},{"key":"265_CR45","doi-asserted-by":"crossref","first-page":"I\u201351","DOI":"10.1161\/01.CIR.0000033308.01553.2B","volume":"106","author":"HM Connolly","year":"2002","unstructured":"Connolly HM, Schaff HV, Mullany CJ, et al. Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling. Circulation. 2002;106:I\u201351\u20136.","journal-title":"Circulation"},{"key":"265_CR46","doi-asserted-by":"crossref","first-page":"I\u201336","DOI":"10.1161\/01.CIR.104.7.e36","volume":"104","author":"HM Connolly","year":"2001","unstructured":"Connolly HM, Schaff HV, Mullany CJ, et al. Surgical management of left-sided carcinoid heart disease. Circulation. 2001;104:I\u201336\u201340.","journal-title":"Circulation"},{"key":"265_CR47","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jtcvs.2010.05.026","volume":"140","author":"A Arghami","year":"2010","unstructured":"Arghami A, Connolly HM, Abel MD, et al. Quadruple valve replacement in patients with carcinoid heart disease. J Thorac Cardiovasc Surg. 2010;140:1432\u20134.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"265_CR48","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0002-8703(91)90045-J","volume":"121","author":"PM Ridker","year":"1991","unstructured":"Ridker PM, Chertow GM, Karlson EW, et al. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J. 1991;121:1835\u20138.","journal-title":"Am Heart J."},{"key":"265_CR49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5223(19)37666-4","volume":"81","author":"FJ Schoen","year":"1981","unstructured":"Schoen FJ, Hausner RJ, Howell JF, et al. Porcine heterograft valve replacement in carcinoid heart disease. J Thor Cardiovasc Surg. 1981;81:100\u20135.","journal-title":"J Thor Cardiovasc Surg."},{"key":"265_CR50","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.athoracsur.2010.07.023","volume":"90","author":"JM Stulak","year":"2010","unstructured":"Stulak JM, Dearani JA, Burkhart HM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg. 2010;90:2009\u201315.","journal-title":"Ann Thorac Surg"},{"key":"265_CR51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bjaceaccp\/mkq045","volume":"11","author":"B Powell","year":"2011","unstructured":"Powell B, Al Mukhtar A, Mills GH. Carcinoid: the disease and its implications for anaesthesia. Contin Educ Anaesthes Crit Care Pain. 2011;11:9\u201313.","journal-title":"Contin Educ Anaesthes Crit Care Pain"},{"key":"265_CR52","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1213\/01.ane.0000284704.57806.0b","volume":"105","author":"TN Weingarten","year":"2007","unstructured":"Weingarten TN, Abel MD, Connolly HM, et al. Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases. Anesth Analg. 2007;105:1192\u20139. This publication details the anesthetic management of consecutive carcinoid heart disease patients undergoing cardiac surgery at a single center and highlights the importance of a multidiscplinary approach in perioperative management and improvement in perioperative survival over time.","journal-title":"Anesth Analg"},{"key":"265_CR53","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","volume":"112","author":"JE M\u00f8ller","year":"2005","unstructured":"M\u00f8ller JE, Pellikka PA, Bernheim AM, et al. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation. 2005;112:3320\u20137. This study demonstrates the improvement in prognosis for metastatic carcinoid disease and carcinoid heart disease over two decades and suggests the important contribution of valvular surgery.","journal-title":"Circulation"},{"key":"265_CR54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","volume":"92","author":"PA Robiolio","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, et al. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995;92:790\u20135.","journal-title":"Circulation"},{"key":"265_CR55","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.0007-1323.2001.01798.x","volume":"88","author":"G Westberg","year":"2001","unstructured":"Westberg G, W\u00e4ngberg B, Ahlman H, et al. Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br J Surg. 2001;88:865\u201372.","journal-title":"Br J Surg"},{"key":"265_CR56","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","volume":"83","author":"BK Eriksson","year":"1998","unstructured":"Eriksson BK, Larsson EG, Skogseid BM, et al. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer. 1998;83:2293\u2013301.","journal-title":"Cancer"},{"key":"265_CR57","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/annonc\/12.suppl_2.S111","volume":"12","author":"K Oberg","year":"2001","unstructured":"Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Ann Oncol. 2001;12:S111\u20134.","journal-title":"Ann Oncol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-013-0265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-013-0265-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-013-0265-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T04:19:27Z","timestamp":1596341967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-013-0265-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,18]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1007\/s11936-013-0265-2","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,18]]}}}